×
About 5,378 results

ALLMedicine™ Hyponatremia Center

Research & Reviews  1,678 results

Alternative birthing practices tied to neonatal infection risk
https://www.mdedge.com/obgyn/article/251075/obstetrics/alternative-birthing-practices-tied-neonatal-infection-risk
Diana Swift

Jan 24th, 2022 - Increasingly popular alternative peripartum practices such as water immersion and nonseverance of the umbilical cord may increase the risk of infections in newborns, a new clinical report from the American Academy of Pediatrics found. Another peri.

Correcting hyponatremia by fluid sodium modulation in continuous renal replacement ther...
https://doi.org/10.1111/sdi.13054
Seminars in Dialysis; Anantharaman S, Chionh CY

Jan 21st, 2022 - A 40-year-old man presented with severe hyponatremia with a serum sodium of 102 mmol/L and concomitant acute kidney injury complicated by severe acidosis. He was started on continuous renal replacement therapy (CRRT) with regional citrate anticoag...

Diabetes Insipidus Treatment & Management
http://emedicine.medscape.com/article/117648-treatment

Jan 20th, 2022 - Approach Considerations Fluid replacement Most patients with diabetes insipidus (DI) can drink enough fluid to replace their urine losses. When oral intake is inadequate and hypernatremia is present, replace losses with dextrose and water or an in...

Urea for Chronic Hyponatremia
https://clinicaltrials.gov/ct2/show/NCT04588207

Jan 20th, 2022 - Hyponatremia is the most common electrolyte disorder encountered clinically. While acute and/or severe hyponatremia is commonly associated with significant symptoms, milder and more chronic forms of hyponatremia remain clinically inconspicuous as ...

Adrenal Crisis
http://emedicine.medscape.com/article/116716-overview

Jan 13th, 2022 - Practice Essentials Do not confuse acute adrenal crisis with Addison disease. In 1855, Thomas Addison described a syndrome of long-term adrenal insufficiency that develops over months to years, with weakness, fatigue, anorexia, weight loss, and hy...

see more →

Guidelines  6 results

International Continence Society consensus on the diagnosis and treatment of nocturia.
https://doi.org/10.1002/nau.23939
Neurourology and Urodynamics; Everaert K, Hervé F et. al.

Feb 20th, 2019 - Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi m...

Choosing Wisely in pediatric anesthesia: An interpretation from the German Scientific W...
https://doi.org/10.1111/pan.13383
Paediatric Anaesthesia; Becke K, Eich C et. al.

Jun 1st, 2018 - Inspired by the Choosing Wisely initiative, a group of pediatric anesthesiologists representing the German Working Group on Paediatric Anaesthesia (WAKKA) coined and agreed upon 10 concise positive ("dos") or negative ("don'ts") evidence-based rec...

Approach to hyponatremia according to the clinical setting: Consensus statement from th...
https://doi.org/10.1007/s40618-017-0776-x
Journal of Endocrinological Investigation; Sbardella E, Isidori AM et. al.

Nov 21st, 2017 - Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).|2017|Sbardella E,Isidori AM,A...

Perioperative intravenous fluid therapy in children: guidelines from the Association of...
https://doi.org/10.1111/pan.13007
Paediatric Anaesthesia; Sümpelmann R, Becke K et. al.

Oct 18th, 2016 - This consensus- based S1 Guideline for perioperative infusion therapy in children is focused on safety and efficacy. The objective is to maintain or re-establish the child's normal physiological state (normovolemia, normal tissue perfusion, normal...

SEOM guidelines on hydroelectrolytic disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239780
Clinical & Translational Oncology : Official Publication ... De las Peñas R, Escobar Y et. al.

Oct 12th, 2014 - Hydroelectrolytic disorders are one of the most common metabolic complications in cancer patients. Although often metabolic alterations affecting various ions are part of the manifestations of the oncological disease, even in the form of paraneopl...

see more →

Drugs  149 results see all →

Clinicaltrials.gov  59 results

Urea for Chronic Hyponatremia
https://clinicaltrials.gov/ct2/show/NCT04588207

Jan 20th, 2022 - Hyponatremia is the most common electrolyte disorder encountered clinically. While acute and/or severe hyponatremia is commonly associated with significant symptoms, milder and more chronic forms of hyponatremia remain clinically inconspicuous as ...

Empagliflozin in Diuretic Refractory Ascites
https://clinicaltrials.gov/ct2/show/NCT05013502

Nov 5th, 2021 - Pharmacologic options for the management of ascites are limited to diuretics only. Each year approximately 10% of patients with cirrhosis develop diuretic-resistant ascites, necessitating the use of more invasive procedures such a paracentesis, tr...

Amiloride in Nephrotic Syndrome
https://clinicaltrials.gov/ct2/show/NCT05079789

Oct 15th, 2021 - The monocenter randomized-controlled AMILOR trial investigates the efficacy of the ENaC blocker amiloride in reducing edema in nephrotic syndrome compared with standard therapy with the loop diuretic furosemide. Patients with acute nephrotic syndr...

HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
https://clinicaltrials.gov/ct2/show/NCT03585257

Aug 2nd, 2021 - Hepatic encephalopathy (HE) is a highly prevalent neuro-cognitive complication of cirrhosis characterized by cognitive dysfunction, and high rate of subsequent mortality and recurrence. HE also places a tremendous burden with a relentless increase...

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
https://clinicaltrials.gov/ct2/show/NCT04447911

Jul 26th, 2021 - Hyponatremia is the most common electrolyte derangement occurring in hospitalized patients. It is usually classified as hypovolemic, euvolemic or hypervolemic. The most common aetiology of euvolemic hyponatremia is the syndrome of inappropriate an...

see more →

News  257 results

Alternative birthing practices tied to neonatal infection risk
https://www.mdedge.com/obgyn/article/251075/obstetrics/alternative-birthing-practices-tied-neonatal-infection-risk
Diana Swift

Jan 24th, 2022 - Increasingly popular alternative peripartum practices such as water immersion and nonseverance of the umbilical cord may increase the risk of infections in newborns, a new clinical report from the American Academy of Pediatrics found. Another peri.

Erdafitinib Continues to Show Efficacy in Urothelial Carcinoma
https://www.medpagetoday.com/hematologyoncology/othercancers/96695

Jan 14th, 2022 - The pan-FGFR tyrosine kinase inhibitor erdafitinib (Balversa) was active and safe in patients with locally advanced or metastatic urothelial carcinoma, according to long-term follow-up of a phase II study. At a median follow-up of 24 months, the i...

Home-based system relieves refractory ascites in cirrhosis
https://www.mdedge.com/internalmedicine/article/249961/hepatology/home-based-system-relieves-refractory-ascites-cirrhosis
Jim Kling

Dec 15th, 2021 - A home-based tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS). For these patients, the current sta.

Immunotherapy/Chemo Combos Remain Go-To Option in Growing Small Cell Lung Cancer Paradigm
https://www.onclive.com/view/immunotherapy-chemo-combos-remain-go-to-option-in-growing-small-cell-lung-cancer-paradigm

Nov 6th, 2021 - Chemoimmunotherapy is the new frontline standard of care for patients with small cell lung cancer (SCLC), explained Taofeek K. Owonikoko, MD, PhD, adding that other novel agents, such as, bispecific T-cell engagers (BiTEs) are in the pipeline and ...

Infigratinib Shows Promising Early Activity in FGFR2-Altered Cholangiocarcinoma
https://www.onclive.com/view/infigratinib-shows-promising-early-activity-in-fgfr2-altered-cholangiocarcinoma

Nov 1st, 2021 - The FGFR inhibitor infigratinib (Truseltiq) demonstrated promising clinical activity and a manageable safety profile in previously treated patients with locally advanced or metastatic cholangiocarcinoma whose tumors harbor FGFR2 gene fusions or re...

see more →

Patient Education  2 results see all →